SCHEMBL22182014

SCHEMBL22182014

Nc1ccc(-c2ccc(NCCCN3C(=O)c4cccc5cccc(c45)C3O)c(N)c2)cc1N

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HEXA P06865 6/20 0.36
▸ HEXB P07686 6/20 0.36
▸ SIRT1 Q96EB6 3/20 0.34
▸ HDAC3 O15379 2/20 0.34
▸ HDAC4 P56524 2/20 0.34
▸ HDAC1 Q13547 2/20 0.34
▸ HDAC7 Q8WUI4 2/20 0.34
▸ HDAC2 Q92769 2/20 0.34
▸ HDAC10 Q969S8 2/20 0.34
▸ HDAC11 Q96DB2 2/20 0.34
▸ HDAC8 Q9BY41 2/20 0.34
▸ HDAC6 Q9UBN7 2/20 0.34
▸ HDAC9 Q9UKV0 2/20 0.34
▸ HDAC5 Q9UQL6 2/20 0.34
▸ NCOR2 Q9Y618 1/20 0.34
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ RGS12 O14924 1/20 0.33
▸ USP2 O75604 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22182108 0.85 USP2 (0.41) HEXAHEXBSIRT1HDAC3HDAC4
SCHEMBL22181988 0.82 SIRT1 (0.53) HEXAHEXBSIRT1HDAC3HDAC4
SCHEMBL22182070 0.76 HEXA (0.36) HEXAHEXBSIRT1L3MBTL1POLB
SCHEMBL22181838 0.74 HDAC3 (0.35) HEXAHEXBSIRT1HDAC3HDAC4
SCHEMBL22181861 0.72 SIRT1 (0.53) HEXAHEXBSIRT1HDAC3HDAC4
SCHEMBL22182013 0.69 HEXA (0.62) HEXAHEXBSIRT1HDAC3HDAC4
SCHEMBL22182116 0.69 TP53 (0.44) HEXAHEXBSIRT1KMT2AMEN1
SCHEMBL22182115 0.69 SIRT1 (0.49) HEXAHEXBSIRT1HDAC3HDAC4
SCHEMBL8243456 0.68 HDAC8 (0.65) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL16213588 0.67 HEXA (0.58) HEXAHEXBL3MBTL1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020139291-A1 NAPHTHALIMIDE DERIVATIVES AS ANTI-PARASITIC AGENTS FOR THE TREATMENT OF LEISHMANIASIS AS WELL AS VIRAL, BACTERIAL AND NEOPLASTIC DISEASES ISTANBUL MEDIPOL UNIVERSITESI (TR) 2020-07-02 — — WO disclosed
Send feedback